

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.80934663 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.80934663 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.60696798 |
| 4 | protein retention in ER lumen (GO:0006621) | 7.31147025 |
| 5 | exocrine pancreas development (GO:0031017) | 7.23869889 |
| 6 | signal peptide processing (GO:0006465) | 6.88236454 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 6.12268596 |
| 8 | protein maturation by protein folding (GO:0022417) | 5.10927527 |
| 9 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.78378758 |
| 10 | COPII vesicle coating (GO:0048208) | 4.74631858 |
| 11 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.70553494 |
| 12 | positive regulation of nuclease activity (GO:0032075) | 4.56615633 |
| 13 | digestion (GO:0007586) | 4.43577118 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.32997183 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32997183 |
| 16 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.25276811 |
| 17 | regulation of nuclease activity (GO:0032069) | 4.22854271 |
| 18 | valine metabolic process (GO:0006573) | 4.18294045 |
| 19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.17936706 |
| 20 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.17401151 |
| 21 | cellular response to unfolded protein (GO:0034620) | 4.12509949 |
| 22 | cellular response to topologically incorrect protein (GO:0035967) | 4.02342581 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.95374706 |
| 24 | response to peptidoglycan (GO:0032494) | 3.93285482 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 3.92860124 |
| 26 | ER-nucleus signaling pathway (GO:0006984) | 3.91164388 |
| 27 | * protein N-linked glycosylation via asparagine (GO:0018279) | 3.90068518 |
| 28 | * peptidyl-asparagine modification (GO:0018196) | 3.85230440 |
| 29 | proline biosynthetic process (GO:0006561) | 3.82052436 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72566212 |
| 31 | response to endoplasmic reticulum stress (GO:0034976) | 3.72377591 |
| 32 | mitochondrial calcium ion transport (GO:0006851) | 3.71244425 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.66060200 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.64008075 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 3.64008075 |
| 36 | endocrine pancreas development (GO:0031018) | 3.63517352 |
| 37 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.62793449 |
| 38 | * protein N-linked glycosylation (GO:0006487) | 3.58921107 |
| 39 | sequestering of metal ion (GO:0051238) | 3.57818528 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.51524069 |
| 41 | regulation of podosome assembly (GO:0071801) | 3.48159822 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 3.45149679 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.45149679 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40617912 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39446513 |
| 46 | intestinal absorption (GO:0050892) | 3.38863983 |
| 47 | transcytosis (GO:0045056) | 3.36722597 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.34191024 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.34191024 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.34191024 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.34191024 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.34191024 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 3.34191024 |
| 54 | detection of other organism (GO:0098543) | 3.33208691 |
| 55 | 4-hydroxyproline metabolic process (GO:0019471) | 3.31539492 |
| 56 | pinocytosis (GO:0006907) | 3.29066986 |
| 57 | cysteine metabolic process (GO:0006534) | 3.25763824 |
| 58 | glycosphingolipid catabolic process (GO:0046479) | 3.22837872 |
| 59 | detection of bacterium (GO:0016045) | 3.19548304 |
| 60 | cell redox homeostasis (GO:0045454) | 3.18115764 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16740209 |
| 62 | sulfur amino acid catabolic process (GO:0000098) | 3.15388715 |
| 63 | peptide catabolic process (GO:0043171) | 3.12516712 |
| 64 | glycolipid catabolic process (GO:0019377) | 3.09982438 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.01323546 |
| 66 | amyloid precursor protein catabolic process (GO:0042987) | 3.00463515 |
| 67 | detection of external biotic stimulus (GO:0098581) | 3.00059806 |
| 68 | B cell mediated immunity (GO:0019724) | 2.99445184 |
| 69 | * response to unfolded protein (GO:0006986) | 2.98356141 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 2.96455206 |
| 71 | vesicle coating (GO:0006901) | 2.95371191 |
| 72 | * response to topologically incorrect protein (GO:0035966) | 2.94169997 |
| 73 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.93219363 |
| 74 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.93219363 |
| 75 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.91901274 |
| 76 | branched-chain amino acid metabolic process (GO:0009081) | 2.89929439 |
| 77 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.89773522 |
| 78 | myeloid dendritic cell activation (GO:0001773) | 2.89384996 |
| 79 | negative regulation of digestive system process (GO:0060457) | 2.88952114 |
| 80 | branched-chain amino acid catabolic process (GO:0009083) | 2.88364591 |
| 81 | negative regulation of cell killing (GO:0031342) | 2.86804841 |
| 82 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86804841 |
| 83 | proline metabolic process (GO:0006560) | 2.86171803 |
| 84 | regulation of superoxide anion generation (GO:0032928) | 2.85370153 |
| 85 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.85132411 |
| 86 | protein targeting to ER (GO:0045047) | 2.83770308 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 2.83701374 |
| 88 | peptide hormone processing (GO:0016486) | 2.83436244 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83269658 |
| 90 | cotranslational protein targeting to membrane (GO:0006613) | 2.83028501 |
| 91 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.82332191 |
| 92 | neutrophil mediated immunity (GO:0002446) | 2.81366292 |
| 93 | cholesterol catabolic process (GO:0006707) | 2.81066917 |
| 94 | sterol catabolic process (GO:0016127) | 2.81066917 |
| 95 | ER overload response (GO:0006983) | 2.80319881 |
| 96 | cellular extravasation (GO:0045123) | 2.79124431 |
| 97 | maintenance of protein localization in organelle (GO:0072595) | 2.79034108 |
| 98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78923303 |
| 99 | protein autoprocessing (GO:0016540) | 2.77345175 |
| 100 | nucleotide-sugar metabolic process (GO:0009225) | 2.76151205 |
| 101 | glandular epithelial cell differentiation (GO:0002067) | 2.73493929 |
| 102 | protein localization to endoplasmic reticulum (GO:0070972) | 2.73353808 |
| 103 | oligosaccharide catabolic process (GO:0009313) | 2.71958979 |
| 104 | macrophage activation involved in immune response (GO:0002281) | 2.71761241 |
| 105 | type I interferon signaling pathway (GO:0060337) | 2.71738018 |
| 106 | cellular response to type I interferon (GO:0071357) | 2.71738018 |
| 107 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.70675317 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.68681194 |
| 109 | amino sugar catabolic process (GO:0046348) | 2.67423921 |
| 110 | cobalamin metabolic process (GO:0009235) | 2.67015485 |
| 111 | response to type I interferon (GO:0034340) | 2.64777367 |
| 112 | ceramide catabolic process (GO:0046514) | 2.64349893 |
| 113 | macrophage activation (GO:0042116) | 2.62359304 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 2.61686701 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61464693 |
| 116 | L-serine metabolic process (GO:0006563) | 2.61393580 |
| 117 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.61074699 |
| 118 | granulocyte activation (GO:0036230) | 2.60963822 |
| 119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.60197054 |
| 120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60176517 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59600859 |
| 122 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.59360658 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.59062641 |
| 124 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58279710 |
| 125 | fucose metabolic process (GO:0006004) | 2.56948022 |
| 126 | complement activation, classical pathway (GO:0006958) | 2.56793768 |
| 127 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.55897005 |
| 128 | neutrophil activation (GO:0042119) | 2.55757697 |
| 129 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55368515 |
| 130 | leukocyte aggregation (GO:0070486) | 2.54840028 |
| 131 | detection of biotic stimulus (GO:0009595) | 2.54675447 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.52604386 |
| 133 | positive regulation of isotype switching (GO:0045830) | 2.52422749 |
| 134 | membrane lipid catabolic process (GO:0046466) | 2.51481999 |
| 135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49895862 |
| 136 | DNA deamination (GO:0045006) | 2.49835322 |
| 137 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.49651033 |
| 138 | negative regulation of interleukin-17 production (GO:0032700) | 2.48502874 |
| 139 | aromatic amino acid family catabolic process (GO:0009074) | 2.48450602 |
| 140 | regulation of cholesterol esterification (GO:0010872) | 2.47179364 |
| 141 | nucleoside diphosphate catabolic process (GO:0009134) | 2.47083259 |
| 142 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.46844808 |
| 143 | pentose-phosphate shunt (GO:0006098) | 2.46002242 |
| 144 | regulation of vitamin metabolic process (GO:0030656) | 2.45923479 |
| 145 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.45625810 |
| 146 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45106070 |
| 147 | zinc ion transport (GO:0006829) | 2.44524207 |
| 148 | beta-amyloid metabolic process (GO:0050435) | 2.44213912 |
| 149 | defense response to protozoan (GO:0042832) | 2.44053550 |
| 150 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43661277 |
| 151 | regulation of chemokine biosynthetic process (GO:0045073) | 2.43067559 |
| 152 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.42555677 |
| 153 | regulation of response to interferon-gamma (GO:0060330) | 2.41702099 |
| 154 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.40979999 |
| 155 | endosome to melanosome transport (GO:0035646) | 2.40462042 |
| 156 | endosome to pigment granule transport (GO:0043485) | 2.40462042 |
| 157 | regulation of leukocyte degranulation (GO:0043300) | 2.39975448 |
| 158 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.38749074 |
| 159 | tricarboxylic acid metabolic process (GO:0072350) | 2.38672255 |
| 160 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.38017857 |
| 161 | respiratory burst (GO:0045730) | 2.37953602 |
| 162 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.37680255 |
| 163 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37333236 |
| 164 | myeloid cell activation involved in immune response (GO:0002275) | 2.37186738 |
| 165 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.36622754 |
| 166 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.36200359 |
| 167 | NADPH regeneration (GO:0006740) | 2.35590992 |
| 168 | peptide metabolic process (GO:0006518) | 2.35432146 |
| 169 | regulation of tolerance induction (GO:0002643) | 2.35102285 |
| 170 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.35029256 |
| 171 | NIK/NF-kappaB signaling (GO:0038061) | 2.34983866 |
| 172 | positive regulation of B cell differentiation (GO:0045579) | 2.34727577 |
| 173 | mature B cell differentiation involved in immune response (GO:0002313) | 2.34584738 |
| 174 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.34317169 |
| 175 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.33884751 |
| 176 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.33441538 |
| 177 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.33349638 |
| 178 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32892057 |
| 179 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.32847957 |
| 180 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.32788320 |
| 181 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.32782846 |
| 182 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.32065332 |
| 183 | dendritic cell differentiation (GO:0097028) | 2.31552244 |
| 184 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.31210953 |
| 185 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.30964040 |
| 186 | regulation of interleukin-17 production (GO:0032660) | 2.28517947 |
| 187 | negative regulation of innate immune response (GO:0045824) | 2.28479266 |
| 188 | regulation of antigen processing and presentation (GO:0002577) | 2.28234607 |
| 189 | positive regulation of B cell mediated immunity (GO:0002714) | 2.28123108 |
| 190 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.28123108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.98921584 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.86172328 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79653026 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.01835944 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.97282778 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.70198488 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.60672597 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.56620858 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.53274351 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.46303893 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32512153 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.29408855 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29239671 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.25729112 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22589816 |
| 16 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14197110 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14048903 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13049760 |
| 19 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.12736570 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12262447 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05966556 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05765745 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.98767783 |
| 24 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.96200575 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95246024 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92800230 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87601427 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87149974 |
| 29 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.86519791 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86299615 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82978500 |
| 32 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81556400 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79114377 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77388701 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74785036 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72639325 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67471146 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66422531 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65285034 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62711284 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60970031 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60549586 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59132477 |
| 44 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59011911 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57538294 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56224172 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55414310 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54935796 |
| 49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54877758 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54761463 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52841426 |
| 52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51368905 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51026582 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.50102675 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47210848 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46246715 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43491890 |
| 58 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.41120529 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40736288 |
| 60 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.39967517 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38119779 |
| 62 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.37871129 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37298226 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35350736 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35114505 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.34084354 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33964079 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33927096 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33130077 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31812905 |
| 71 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31445266 |
| 72 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29102257 |
| 73 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29008603 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28949619 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28919940 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28274684 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28273721 |
| 78 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27301460 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26976952 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26919400 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26878074 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26209161 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24220818 |
| 84 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23817364 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23349398 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21075238 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18995642 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17700412 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.17388220 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17273415 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16749990 |
| 92 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15208536 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14074823 |
| 94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13072011 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12130998 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12065312 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11630397 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10369461 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08388694 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07451199 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 1.07405694 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06540387 |
| 103 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04968869 |
| 104 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04816727 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03533293 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02796975 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02571812 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02393643 |
| 109 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02359677 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02273020 |
| 111 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01884084 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01568865 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01395624 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00913757 |
| 115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00814310 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00777816 |
| 117 | MAF_26560356_Chip-Seq_TH1_Human | 1.00478729 |
| 118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.99947658 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99095359 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98459350 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98011196 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97343798 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97028819 |
| 124 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95841732 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95704797 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94388475 |
| 127 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94375453 |
| 128 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93998551 |
| 129 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93725071 |
| 130 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93266259 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92293806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005365_abnormal_bile_salt | 4.31122701 |
| 2 | MP0005083_abnormal_biliary_tract | 4.28515797 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.27549917 |
| 4 | MP0005220_abnormal_exocrine_pancreas | 3.95842134 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.28243781 |
| 6 | MP0003183_abnormal_peptide_metabolism | 2.79286848 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.74583780 |
| 8 | MP0002693_abnormal_pancreas_physiology | 2.71632364 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.70801143 |
| 10 | MP0003868_abnormal_feces_composition | 2.51861382 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.48402137 |
| 12 | MP0005451_abnormal_body_composition | 2.25755544 |
| 13 | MP0008260_abnormal_autophagy | 2.18986686 |
| 14 | MP0001944_abnormal_pancreas_morphology | 2.13051129 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.08637176 |
| 16 | MP0009840_abnormal_foam_cell | 2.07188009 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 2.03472202 |
| 18 | MP0003195_calcinosis | 1.95589273 |
| 19 | MP0001853_heart_inflammation | 1.89310337 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.89135763 |
| 21 | MP0006054_spinal_hemorrhage | 1.85233332 |
| 22 | MP0005360_urolithiasis | 1.84706588 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.75382494 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.71450065 |
| 25 | MP0003436_decreased_susceptibility_to | 1.71014195 |
| 26 | MP0003186_abnormal_redox_activity | 1.70796695 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69601422 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.69049323 |
| 29 | MP0003075_altered_response_to | 1.68745205 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.67061429 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.60403987 |
| 32 | MP0000604_amyloidosis | 1.60003944 |
| 33 | MP0005310_abnormal_salivary_gland | 1.55435776 |
| 34 | MP0005671_abnormal_response_to | 1.51426410 |
| 35 | MP0003252_abnormal_bile_duct | 1.50474221 |
| 36 | MP0009785_altered_susceptibility_to | 1.50008610 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.49579237 |
| 38 | MP0009764_decreased_sensitivity_to | 1.43947875 |
| 39 | MP0000343_altered_response_to | 1.43716013 |
| 40 | MP0005025_abnormal_response_to | 1.43675878 |
| 41 | MP0002419_abnormal_innate_immunity | 1.43467538 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.43428476 |
| 43 | MP0004043_abnormal_pH_regulation | 1.43361406 |
| 44 | MP0003724_increased_susceptibility_to | 1.43026671 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.41916955 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.41277760 |
| 47 | MP0005332_abnormal_amino_acid | 1.39609702 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.38919869 |
| 49 | MP0001764_abnormal_homeostasis | 1.38264389 |
| 50 | MP0001873_stomach_inflammation | 1.34554847 |
| 51 | MP0000609_abnormal_liver_physiology | 1.33653292 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.32879078 |
| 53 | MP0000685_abnormal_immune_system | 1.32333043 |
| 54 | MP0008469_abnormal_protein_level | 1.31877270 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.30810751 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.29253507 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.28849100 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 1.27939479 |
| 59 | MP0000490_abnormal_crypts_of | 1.27770671 |
| 60 | MP0009278_abnormal_bone_marrow | 1.25698174 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.25531851 |
| 62 | MP0000613_abnormal_salivary_gland | 1.25185044 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.24582679 |
| 64 | MP0003448_altered_tumor_morphology | 1.24477651 |
| 65 | MP0005379_endocrine/exocrine_gland_phen | 1.22460207 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.21666277 |
| 67 | MP0002723_abnormal_immune_serum | 1.21501694 |
| 68 | MP0005408_hypopigmentation | 1.20138292 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.19127271 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.19127271 |
| 71 | MP0003866_abnormal_defecation | 1.19078927 |
| 72 | MP0001800_abnormal_humoral_immune | 1.18554661 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.16856649 |
| 74 | MP0003693_abnormal_embryo_hatching | 1.13679414 |
| 75 | MP0006082_CNS_inflammation | 1.13123583 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.12897595 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.12690060 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.10886105 |
| 79 | MP0001819_abnormal_immune_cell | 1.10165246 |
| 80 | MP0005166_decreased_susceptibility_to | 1.09045388 |
| 81 | MP0003959_abnormal_lean_body | 1.08790743 |
| 82 | MP0002722_abnormal_immune_system | 1.08610488 |
| 83 | MP0005164_abnormal_response_to | 1.05811582 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.05793396 |
| 85 | MP0001790_abnormal_immune_system | 1.05186111 |
| 86 | MP0005387_immune_system_phenotype | 1.05186111 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 1.04182999 |
| 88 | MP0001664_abnormal_digestion | 1.03071171 |
| 89 | MP0002132_abnormal_respiratory_system | 1.02405672 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.99569385 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.99279629 |
| 92 | MP0000598_abnormal_liver_morphology | 0.99272459 |
| 93 | MP0001756_abnormal_urination | 0.99112996 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.99058580 |
| 95 | MP0003828_pulmonary_edema | 0.98877747 |
| 96 | MP0002928_abnormal_bile_duct | 0.97090405 |
| 97 | MP0005165_increased_susceptibility_to | 0.94056639 |
| 98 | MP0002405_respiratory_system_inflammati | 0.93154316 |
| 99 | MP0004947_skin_inflammation | 0.91938970 |
| 100 | MP0003303_peritoneal_inflammation | 0.91927823 |
| 101 | MP0005023_abnormal_wound_healing | 0.91304189 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.91082361 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.90368280 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.89505210 |
| 105 | MP0006036_abnormal_mitochondrial_physio | 0.89040442 |
| 106 | MP0002933_joint_inflammation | 0.88718778 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.88547493 |
| 108 | MP0000716_abnormal_immune_system | 0.87676219 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.87605014 |
| 110 | MP0002006_tumorigenesis | 0.86283680 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.85242241 |
| 112 | MP0004883_abnormal_blood_vessel | 0.83388335 |
| 113 | MP0008004_abnormal_stomach_pH | 0.83346318 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.83178565 |
| 115 | MP0001851_eye_inflammation | 0.82586012 |
| 116 | MP0002398_abnormal_bone_marrow | 0.82046974 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.82021669 |
| 118 | MP0005390_skeleton_phenotype | 0.81654146 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81221738 |
| 120 | MP0003690_abnormal_glial_cell | 0.81068883 |
| 121 | MP0001958_emphysema | 0.80845680 |
| 122 | MP0009763_increased_sensitivity_to | 0.80677585 |
| 123 | MP0000858_altered_metastatic_potential | 0.80345639 |
| 124 | MP0002429_abnormal_blood_cell | 0.79858629 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.79564075 |
| 126 | MP0001915_intracranial_hemorrhage | 0.79523772 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.78971768 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.78503079 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.78334372 |
| 130 | MP0003795_abnormal_bone_structure | 0.77755845 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.73944488 |
| 132 | MP0003091_abnormal_cell_migration | 0.72332411 |
| 133 | MP0002254_reproductive_system_inflammat | 0.71819658 |
| 134 | MP0000249_abnormal_blood_vessel | 0.70621372 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.70142546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 4.53884906 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.39964293 |
| 3 | Hypoglycemic coma (HP:0001325) | 4.18262693 |
| 4 | Abnormality of the intrinsic pathway (HP:0010989) | 3.94972705 |
| 5 | Dysostosis multiplex (HP:0000943) | 3.92538075 |
| 6 | Hypoglycemic seizures (HP:0002173) | 3.75150702 |
| 7 | Abnormal protein glycosylation (HP:0012346) | 3.60360653 |
| 8 | Abnormal glycosylation (HP:0012345) | 3.60360653 |
| 9 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.60360653 |
| 10 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.60360653 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 3.55568261 |
| 12 | Mucopolysacchariduria (HP:0008155) | 3.52623596 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.52623596 |
| 14 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.45028314 |
| 15 | Myositis (HP:0100614) | 3.38289985 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.33030258 |
| 17 | Fat malabsorption (HP:0002630) | 3.31762796 |
| 18 | Steatorrhea (HP:0002570) | 3.31475446 |
| 19 | Loss of speech (HP:0002371) | 3.29364189 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.29000983 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.25917609 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.25917609 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.25917609 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.22520573 |
| 25 | Symptomatic seizures (HP:0011145) | 3.11909986 |
| 26 | Stomatitis (HP:0010280) | 3.07848727 |
| 27 | Orchitis (HP:0100796) | 3.06972440 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.04375494 |
| 29 | Thrombocytosis (HP:0001894) | 3.00791160 |
| 30 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.93125395 |
| 31 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.93125395 |
| 32 | Hepatosplenomegaly (HP:0001433) | 2.85778431 |
| 33 | Ketosis (HP:0001946) | 2.84740671 |
| 34 | Ketoacidosis (HP:0001993) | 2.84723332 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.83234697 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81837313 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81837313 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81837313 |
| 39 | Late onset (HP:0003584) | 2.78837670 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.76518447 |
| 41 | Gout (HP:0001997) | 2.76044027 |
| 42 | Progressive neurologic deterioration (HP:0002344) | 2.73382424 |
| 43 | Obstructive lung disease (HP:0006536) | 2.73330413 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73330413 |
| 45 | Purpura (HP:0000979) | 2.70976979 |
| 46 | Deep venous thrombosis (HP:0002625) | 2.66916049 |
| 47 | Amyloidosis (HP:0011034) | 2.66196161 |
| 48 | Intrahepatic cholestasis (HP:0001406) | 2.65520730 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62735818 |
| 50 | Optic neuritis (HP:0100653) | 2.59838864 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.59838864 |
| 52 | Increased serum ferritin (HP:0003281) | 2.59747300 |
| 53 | Recurrent skin infections (HP:0001581) | 2.57189783 |
| 54 | Myocardial infarction (HP:0001658) | 2.55163386 |
| 55 | Increased IgM level (HP:0003496) | 2.54740751 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.53656272 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.52370719 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50470695 |
| 59 | Glomerulonephritis (HP:0000099) | 2.48092323 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.46947776 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.46448063 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.45123404 |
| 63 | Pancreatitis (HP:0001733) | 2.43931799 |
| 64 | IgM deficiency (HP:0002850) | 2.43067714 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.41282524 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40812436 |
| 67 | Exocrine pancreatic insufficiency (HP:0001738) | 2.38513330 |
| 68 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37433358 |
| 69 | Gingival bleeding (HP:0000225) | 2.34281840 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34218041 |
| 71 | Recurrent abscess formation (HP:0002722) | 2.32360474 |
| 72 | Abnormality of complement system (HP:0005339) | 2.27725326 |
| 73 | Meningitis (HP:0001287) | 2.25037169 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24876184 |
| 75 | Urticaria (HP:0001025) | 2.23694176 |
| 76 | Beaking of vertebral bodies (HP:0004568) | 2.23457046 |
| 77 | Gingivitis (HP:0000230) | 2.22016697 |
| 78 | Epistaxis (HP:0000421) | 2.21597143 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.19565284 |
| 80 | Aplastic anemia (HP:0001915) | 2.18117972 |
| 81 | Prolonged partial thromboplastin time (HP:0003645) | 2.14497836 |
| 82 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.14382486 |
| 83 | Limb hypertonia (HP:0002509) | 2.13829202 |
| 84 | Type I diabetes mellitus (HP:0100651) | 2.12528268 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.11374882 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.11073691 |
| 87 | Retinal atrophy (HP:0001105) | 2.10631210 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10411272 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 2.09987924 |
| 90 | Large for gestational age (HP:0001520) | 2.07113866 |
| 91 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.06145549 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.05891878 |
| 93 | Abnormality of macrophages (HP:0004311) | 2.04752004 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.04377259 |
| 95 | Pulmonary infiltrates (HP:0002113) | 2.04062644 |
| 96 | Hyperbilirubinemia (HP:0002904) | 2.03704709 |
| 97 | Abnormal pancreas size (HP:0012094) | 2.03221625 |
| 98 | Vasculitis (HP:0002633) | 2.02421106 |
| 99 | Upper motor neuron abnormality (HP:0002127) | 2.00355687 |
| 100 | Fatigue (HP:0012378) | 2.00032753 |
| 101 | Episodic fever (HP:0001954) | 1.99635689 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 1.97845154 |
| 103 | Cellulitis (HP:0100658) | 1.97295314 |
| 104 | Petechiae (HP:0000967) | 1.96950013 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 1.96692249 |
| 106 | Cholecystitis (HP:0001082) | 1.96692249 |
| 107 | Hypoplasia of the pons (HP:0012110) | 1.96322559 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 1.95315465 |
| 109 | Pustule (HP:0200039) | 1.95237459 |
| 110 | Eczematoid dermatitis (HP:0000976) | 1.95062214 |
| 111 | Joint stiffness (HP:0001387) | 1.94673208 |
| 112 | Anorexia (HP:0002039) | 1.92743320 |
| 113 | Xanthomatosis (HP:0000991) | 1.92698945 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 1.91695719 |
| 115 | Dicarboxylic aciduria (HP:0003215) | 1.91661377 |
| 116 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.91661377 |
| 117 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.90515207 |
| 118 | Disinhibition (HP:0000734) | 1.90439303 |
| 119 | Chronic otitis media (HP:0000389) | 1.90394268 |
| 120 | T lymphocytopenia (HP:0005403) | 1.89543583 |
| 121 | Abnormality of the pons (HP:0007361) | 1.89490201 |
| 122 | Encephalitis (HP:0002383) | 1.89281800 |
| 123 | Inflammation of the large intestine (HP:0002037) | 1.87257411 |
| 124 | Spontaneous hematomas (HP:0007420) | 1.86939610 |
| 125 | Abdominal distention (HP:0003270) | 1.85833489 |
| 126 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85611526 |
| 127 | Abnormality of purine metabolism (HP:0004352) | 1.85553406 |
| 128 | Hyperglycemia (HP:0003074) | 1.85470307 |
| 129 | Glomerulopathy (HP:0100820) | 1.82793802 |
| 130 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82758300 |
| 131 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82758300 |
| 132 | Recurrent viral infections (HP:0004429) | 1.82516110 |
| 133 | Mucosal telangiectasiae (HP:0100579) | 1.82355533 |
| 134 | Prolonged bleeding time (HP:0003010) | 1.82254001 |
| 135 | Recurrent bronchitis (HP:0002837) | 1.82229024 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81465144 |
| 137 | Osteomyelitis (HP:0002754) | 1.81453854 |
| 138 | Progressive muscle weakness (HP:0003323) | 1.81439568 |
| 139 | Joint swelling (HP:0001386) | 1.81178988 |
| 140 | Abnormality of T cell number (HP:0011839) | 1.80661844 |
| 141 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80607817 |
| 142 | Joint hemorrhage (HP:0005261) | 1.79392114 |
| 143 | Decreased subcutaneous fat (HP:0001002) | 1.79383904 |
| 144 | Nonimmune hydrops fetalis (HP:0001790) | 1.77962346 |
| 145 | Increased IgE level (HP:0003212) | 1.77749214 |
| 146 | Periodontitis (HP:0000704) | 1.77250196 |
| 147 | Colitis (HP:0002583) | 1.76807777 |
| 148 | Opisthotonus (HP:0002179) | 1.76211634 |
| 149 | Acute hepatic failure (HP:0006554) | 1.75497870 |
| 150 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.75119086 |
| 151 | Keratoconjunctivitis sicca (HP:0001097) | 1.75063131 |
| 152 | Pulmonary embolism (HP:0002204) | 1.73909449 |
| 153 | Complement deficiency (HP:0004431) | 1.73468853 |
| 154 | Lower limb hyperreflexia (HP:0002395) | 1.73331714 |
| 155 | Arterial thrombosis (HP:0004420) | 1.73159022 |
| 156 | Polyneuropathy (HP:0001271) | 1.73104686 |
| 157 | Malnutrition (HP:0004395) | 1.72143415 |
| 158 | Hemoptysis (HP:0002105) | 1.71594626 |
| 159 | Splenomegaly (HP:0001744) | 1.70600817 |
| 160 | Impaired platelet aggregation (HP:0003540) | 1.70236343 |
| 161 | Abnormal platelet function (HP:0011869) | 1.70236343 |
| 162 | Hypoplasia of the thymus (HP:0000778) | 1.70072360 |
| 163 | Hemorrhage of the eye (HP:0011885) | 1.70050364 |
| 164 | Hyperammonemia (HP:0001987) | 1.69904473 |
| 165 | Cardiomegaly (HP:0001640) | 1.69880796 |
| 166 | Hematochezia (HP:0002573) | 1.69396256 |
| 167 | Increased CSF protein (HP:0002922) | 1.68447658 |
| 168 | Granulocytopenia (HP:0001913) | 1.68430288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.62277162 |
| 2 | BCKDK | 4.82580403 |
| 3 | TAOK3 | 3.99507134 |
| 4 | EIF2AK3 | 3.21428926 |
| 5 | INSRR | 3.00792982 |
| 6 | PASK | 2.91923950 |
| 7 | MAPK15 | 2.67656218 |
| 8 | RIPK4 | 2.56434779 |
| 9 | FLT3 | 2.50833414 |
| 10 | IRAK3 | 2.47635995 |
| 11 | SCYL2 | 2.44988238 |
| 12 | STK16 | 2.32044631 |
| 13 | IRAK4 | 2.27538761 |
| 14 | NME2 | 2.16774638 |
| 15 | MAP4K1 | 1.95378424 |
| 16 | TYK2 | 1.93972453 |
| 17 | TBK1 | 1.92824903 |
| 18 | ZAP70 | 1.90898270 |
| 19 | PRPF4B | 1.81625915 |
| 20 | MAP2K2 | 1.72075064 |
| 21 | MAPKAPK3 | 1.56043235 |
| 22 | JAK3 | 1.53226665 |
| 23 | TAOK2 | 1.46135268 |
| 24 | KIT | 1.41556465 |
| 25 | IKBKE | 1.38161142 |
| 26 | HIPK2 | 1.38123209 |
| 27 | BTK | 1.37922597 |
| 28 | FGR | 1.36037846 |
| 29 | SIK3 | 1.32874483 |
| 30 | EEF2K | 1.26611595 |
| 31 | BRSK2 | 1.23248252 |
| 32 | TEC | 1.22251144 |
| 33 | PIK3CG | 1.21864475 |
| 34 | ARAF | 1.20894410 |
| 35 | FGFR4 | 1.12019255 |
| 36 | TRIB3 | 1.11801862 |
| 37 | SIK1 | 1.08686292 |
| 38 | MAP3K12 | 1.07348078 |
| 39 | EPHA3 | 1.07150636 |
| 40 | HCK | 1.06884575 |
| 41 | PDK2 | 1.05506182 |
| 42 | PKN2 | 1.05414849 |
| 43 | BMPR2 | 1.03568085 |
| 44 | ACVR1B | 1.03335427 |
| 45 | GRK7 | 1.00606182 |
| 46 | TNK2 | 1.00210962 |
| 47 | BLK | 0.97794110 |
| 48 | CSF1R | 0.97305374 |
| 49 | EPHB1 | 0.95914337 |
| 50 | KDR | 0.92709094 |
| 51 | IRAK1 | 0.92096569 |
| 52 | MAP3K13 | 0.90667224 |
| 53 | MAP3K14 | 0.85967187 |
| 54 | CAMKK2 | 0.85260248 |
| 55 | PTK6 | 0.83621476 |
| 56 | RPS6KB2 | 0.82999483 |
| 57 | MAP2K3 | 0.82843530 |
| 58 | MAP3K1 | 0.81344564 |
| 59 | SYK | 0.80084703 |
| 60 | FRK | 0.77188860 |
| 61 | MOS | 0.75845467 |
| 62 | JAK2 | 0.75755546 |
| 63 | TGFBR2 | 0.75309653 |
| 64 | JAK1 | 0.74901874 |
| 65 | ITK | 0.73587946 |
| 66 | IRAK2 | 0.73354872 |
| 67 | LIMK1 | 0.71876250 |
| 68 | MAP3K2 | 0.71870885 |
| 69 | MARK3 | 0.71042280 |
| 70 | MST4 | 0.71040669 |
| 71 | TAOK1 | 0.69551807 |
| 72 | PIM2 | 0.69264243 |
| 73 | TESK2 | 0.69081963 |
| 74 | EPHA2 | 0.68828978 |
| 75 | LATS1 | 0.68255550 |
| 76 | VRK2 | 0.67646483 |
| 77 | LRRK2 | 0.66577922 |
| 78 | LYN | 0.66410696 |
| 79 | IKBKB | 0.64147817 |
| 80 | NEK9 | 0.62214180 |
| 81 | EIF2AK1 | 0.59909191 |
| 82 | MAP3K3 | 0.59330863 |
| 83 | ADRBK2 | 0.58907751 |
| 84 | CSK | 0.58213752 |
| 85 | PDPK1 | 0.57707809 |
| 86 | PBK | 0.57444792 |
| 87 | PRKG2 | 0.56054906 |
| 88 | NUAK1 | 0.55874622 |
| 89 | RIPK1 | 0.55190193 |
| 90 | TIE1 | 0.55012637 |
| 91 | RPS6KA4 | 0.54615981 |
| 92 | MAP3K5 | 0.54045477 |
| 93 | MST1R | 0.53572377 |
| 94 | NLK | 0.53001500 |
| 95 | WNK4 | 0.51527756 |
| 96 | FGFR3 | 0.50795943 |
| 97 | MATK | 0.50263091 |
| 98 | PDK1 | 0.49659784 |
| 99 | SMG1 | 0.49155142 |
| 100 | MAPK11 | 0.49105854 |
| 101 | CDK6 | 0.48948303 |
| 102 | LCK | 0.48819819 |
| 103 | MAPKAPK5 | 0.46003432 |
| 104 | STK10 | 0.45761360 |
| 105 | KSR2 | 0.45499924 |
| 106 | TXK | 0.43034631 |
| 107 | ILK | 0.43008727 |
| 108 | DDR2 | 0.42606145 |
| 109 | CDC42BPA | 0.42001177 |
| 110 | LMTK2 | 0.41713791 |
| 111 | CHUK | 0.41691536 |
| 112 | PAK1 | 0.40999002 |
| 113 | VRK1 | 0.40995492 |
| 114 | GRK6 | 0.39651598 |
| 115 | MYLK | 0.39649781 |
| 116 | DYRK1B | 0.39563050 |
| 117 | ABL1 | 0.37000775 |
| 118 | MAP3K11 | 0.36114244 |
| 119 | PAK4 | 0.35941237 |
| 120 | MAP3K8 | 0.35371975 |
| 121 | ABL2 | 0.35195648 |
| 122 | FES | 0.34374679 |
| 123 | MAPKAPK2 | 0.32414612 |
| 124 | DYRK3 | 0.32254016 |
| 125 | CDK8 | 0.30936760 |
| 126 | PIM1 | 0.29558791 |
| 127 | BMPR1B | 0.28840093 |
| 128 | CDK19 | 0.28159762 |
| 129 | PAK2 | 0.27524348 |
| 130 | MAP2K6 | 0.25348847 |
| 131 | PTK2 | 0.24937314 |
| 132 | PRKCD | 0.24834933 |
| 133 | TGFBR1 | 0.23795828 |
| 134 | MAPK3 | 0.22931553 |
| 135 | TESK1 | 0.21932877 |
| 136 | RPS6KA6 | 0.21819499 |
| 137 | PRKCI | 0.20236590 |
| 138 | BRAF | 0.19230380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.70815995 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.21816924 |
| 3 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.24646878 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.92331212 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.63159261 |
| 6 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.59291435 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.47484640 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.46625263 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.38448271 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.35095716 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26513774 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21452539 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05386956 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96615000 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.94775833 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.81180524 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78794377 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.76829774 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76755737 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71842102 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.70133670 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.67035272 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.66587735 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61342781 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60186108 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.55901013 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.51241474 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50944449 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.48164155 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.45646835 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.39043998 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37889600 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34180604 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26441061 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25099780 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22686202 |
| 37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.22297474 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20518759 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18428041 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17194067 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.14258452 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14205849 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13108878 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11605846 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11484351 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09600957 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09380708 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08178118 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.06296647 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03104003 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01952707 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.01616815 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01274334 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00112556 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98645138 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96469458 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92445478 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91882105 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.90470902 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89331809 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88330626 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87552679 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86994742 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86622271 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85274285 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83832091 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83532525 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81675676 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81103231 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80667552 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79364788 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78616519 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78491662 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78155724 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76358282 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75924741 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75711622 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.74948779 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.74440991 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74420274 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73813153 |
| 82 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73782186 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72881734 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71344725 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71265799 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70588693 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70374531 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70262151 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69786067 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68828338 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.68715493 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67489963 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.66949791 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66684457 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65685799 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64527723 |
| 97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64231014 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64062296 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63941374 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.63861649 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63642812 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63149349 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62174411 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60727429 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60471533 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60268482 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59861196 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57499743 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57089238 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.55717985 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54521830 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54148792 |
| 113 | Proteasome_Homo sapiens_hsa03050 | 0.53860431 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53707471 |
| 115 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53075524 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52207142 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46031060 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44599583 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.44564086 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43707543 |
| 121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43686159 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42885892 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.42849040 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41906601 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41169710 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.40993189 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40958888 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40784499 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.40086739 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39455053 |
| 131 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38967734 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38857607 |
| 133 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38001038 |
| 134 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36912022 |
| 135 | Measles_Homo sapiens_hsa05162 | 0.35274622 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35242351 |
| 137 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33722027 |
| 138 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33087205 |
| 139 | Mineral absorption_Homo sapiens_hsa04978 | 0.32385388 |
| 140 | DNA replication_Homo sapiens_hsa03030 | 0.32233068 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27342525 |
| 142 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26930203 |
| 143 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.24523195 |
| 144 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24034055 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23517638 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.23467279 |

